2023 Competition Pharmaceutical manufacturing 
European Pharmaceutical Review
FEBRUARY 13, 2025
Based on the new cost estimates, pharmaceutical manufacturers in Finland alone will be required to fund 280816 million of these expenses, The directive , enforced on 1 January 2025, imposes an extended manufacturer responsibility on the removal of micro-pollutants from wastewaters.
European Pharmaceutical Review
NOVEMBER 14, 2023
Yet these industries have faced disruptions and changes in operating environments, resulting in major challenges to overcome, in addition to a new era of global competition driven by targeted national industrial strategies, according to the ABPI. Combined, these sectors have a turnover of £309 billion, ABPI highlighted.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharmaceutical Technology
DECEMBER 19, 2022
in 2022 to 1% in 2023 due to the “tightening of monetary and financial conditions”. Furthermore, for months, several financial institutions such as Bank of America and JP Morgan have been talking of a “mild recession” in 2023 for the US. by the end of 2023 and may continue to rise in 2024 to 5%.
pharmaphorum
DECEMBER 28, 2022
M&A is an integral part of the lifecycle of pharma companies and a key strategy to future-proof larger players, driving R&D activities and innovation for a competitive product pipeline. Due diligence teams will review your pharmaceutical quality system – to verify if it is operational and effective.
Impetus Digital
AUGUST 2, 2024
Looking back at 2023 , AI for drug discovery saw both wins and losses. Manufacturing Optimization While the manufacturing industry lags behind others in terms of AI uptake, there is no shortage of potential ways to leverage this technology. In 2022, the AI-fuelled pipeline reportedly expanded at an annual rate of almost 40%.
European Pharmaceutical Review
NOVEMBER 8, 2022
Pharmaceutical manufacturers have submitted Citizen Petitions raising safety or efficacy concerns about proposed competing generic and biosimilar products, and such submissions often delay FDA approval of the proposed products while the FDA resolves the pending petitions.
PM360
SEPTEMBER 30, 2024
This article outlines how developers can utilize sustainability initiatives to boost revenue, reduce costs, and advance innovation, ensuring a strategic, long-term, and more sustainable position in today’s competitive landscape.
Expert insights. Personalized for you.
59 
Let's personalize your content